Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05343494 · ClinicalTrials.gov registry record · NA
Maternal Health Diabetes Prevention Study
A NA study of PreDiabetes and Gestational Diabetes, sponsored by Tulane University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05343494: Completed NA study of PreDiabetes and Gestational Diabetes, sponsored by Tulane University.
NCT05343494 is a NA study of PreDiabetes and Gestational Diabetes that has completed, run by Tulane University. The registered enrollment target is 20 participants, below the 701-participant average among 149 other PreDiabetes trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05343494, a NA study of PreDiabetes and Gestational Diabetes, has completed, sponsored by Tulane University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this project is to use the Exploration, Preparation, Implementation, Sustainment (EPIS) framework to collect pilot data on the implementation of a Diabetes Prevention Program-like intervention in the Women, Infants, and Children (WIC) program.
Primary Outcome
Number of sessions attended throughout the 8 week intervention
Conditions Studied
Interventions
- BEHAVIORAL Lifestyle Intervention
Study Locations (1)
Louisiana
- Tulane Office of Health Research - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-04-04 |
| Est. Completion | 2022-10-05 |
| Phase | NA |
What the finished NCT05343494 record still lists
NCT05343494 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 701-participant average among 149 other PreDiabetes trials with a reported enrollment target (97% lower).
The record links to 4 conditions, with PreDiabetes appearing as the primary indexed condition, and to 1 intervention - of which Lifestyle Intervention is the first listed.
NCT05343494 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT05343494 about?
NCT05343494 is a clinical study titled "Maternal Health Diabetes Prevention Study". The aim of this project is to use the Exploration, Preparation, Implementation, Sustainment (EPIS) framework to collect pilot data on the implementation of a Diabetes Prevention Program-like intervention in the Women, Infants, and Children (WIC) program.
What is the current status of trial NCT05343494?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2022-04-04. Estimated completion is 2022-10-05.
What conditions does trial NCT05343494 study?
This clinical trial studies the following conditions: PreDiabetes, Gestational Diabetes, Hyperglycemia, Glucose Intolerance During Pregnancy.
What interventions are being tested in trial NCT05343494?
The interventions under investigation include: Lifestyle Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05343494?
This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05343494 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PreDiabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05343494's enrollment target sits among peer trials
20 133rd of 149 higher than 10 of 149 other PreDiabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PreDiabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Diabetes Clinical Decision Support
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
-
Cleaner Air for Lower Cardiometabolic Risk
RECRUITING · NA
-
Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI